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We report a 4-generation Turkish family with 10 affected mem-
bers  presenting  with  myotonia  and  potassium-  and  exercise-
induced paralytic attacks. The clinical presentation was neither 
typical for the chloride channel myotonias Thomsen and Becker 
nor for the separate sodium channel myotonia entities potassium-
aggravated myotonia, paramyotonia congenita, and hyperkale-
mic periodic paralysis. It is best described by a combination of 
potassium-aggravated myotonia and hyperkalemic periodic pa-
ralysis. We excluded exonic chloride channel mutations including 
CLCN1 exon deletion/duplication by MLPA. Instead we identi-
fied a novel p.N440K sodium channel mutation that is located at 
the inner end of segment S6 of repeat I. We discuss the genotype 
phenotype relation.
Key words: chloride channel myotonia Thomsen and Becker, sodi-
um channel myotonia, hyperkalemic periodic paralysis, potassium-
aggravated myotonia, paramyotonia congenita, CLCN1, MLPA
Recurring episodes of muscle stiffness or weakness 
are usually triggered by typical circumstances such as 
rest, exercise, oral K+ load, or cold environment.
Introduction
In the classical Thomsen myotonia and the more fre-
quent Becker myotonia, muscle stiffness is generalized, 
most severe after rest and improves with continued ex-
ercise (warm-up phenomenon). Myotonic stiffness can 
be associated with weakness (transient weakness) but is 
not aggravated by cold (1) although many authors believe 
that any kind of myotonia worsens with exposure to cold. 
Both types are caused by CLCN1 mutations (2).
In  paramyotonia  congenita  (PMC),  myotonia  is 
induced by cold (Table 1) and aggravated by repeated 
contractions (paradoxical myotonia). It is usually fol-
lowed by flaccid weakness that lasts for several hours. 
This type of myotonia is caused by a sodium channel 
defect (3, 4).
In potassium-aggravated myotonia (PAM), episodes 
of weakness do not occur (5). This myotonia is exacerbat-
ed by rest following exercise (delayed myotonia) (6, 7). 
The potassium dependence can be used to differentiate 
PAM from chloride channel myotonias. The variability 
of PAM is large, ranging from mild myotonia fluctuans to 
severe myotonia permanens (6-11). As in the other forms 
of myotonia, myotonia in PAM results from uncontrolled 
repetitive action potentials.
The contrary, potassium-induced lack of action po-
tentials resulting in muscle weakness, occurs in hyper-
kalemic periodic paralysis (HyperPP). HyperPP is char-
acterized by episodes of flaccid muscle weakness which 
are  not  only  produced  by  ingestion  of  potassium-rich 
food but are often triggered by rest, particularly after ex-
ercise (12). The spontaneous attacks usually begin early 
in the day (before breakfast) and can last for minutes to 
hours. Clinical myotonia is not common in HyperPP but 
may precede an attack, and myotonic activity is usually 
detected at rest with needle EMG (latent myotonia) (13).
Here we report a myotonic family with an unusual 
clinical phenotype consisting of PAM with potassium- 
and exercise-induced weakness. This is caused by a novel 
mutation in a non-hotspot area of the sodium channel pro-
tein.
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Materials and methods
Members of the family participating in the study gave 
their informed consent. Experiments were approved of by 
the Ethics Committee of Ulm University and were in con-
cordance with the Declaration of Helsinki. The affected 
individuals were neurologically examined by one of the 
authors. Electromyography (EMG) and nerve conduction 
velocities were determined in several members as well 
as molecular genetics. In the proband, potassium provo-
cation, bicycle exercise, and cooling were performed as 
provocation tests.
Provocation tests: Potassium (60 mmol) was orally 
administered  in  an  unsweetened  solution  in  the  fast-
ing state. Serum potassium levels were determined ap-
proximately in intervals of 20 minutes prior to and after 
ingestion, the ECG monitored and an anaesthetist avail-
able in case of a wide-spread paralysis involving respi-
ratory muscles. After the ingestion, the patient avoided 
all muscle activity. In addition, exercise on a bicycle was 
performed for 25 minutes with a load that increased the 
pulse rate to 120-160 beats/min. This test was followed 
by absolute rest. In the cooling test, one forearm was 
cooled for 30 minutes in water of 15°C. Subsequently the 
patient performed repetitive strong fist closures and open-
ings. Muscle strength was always scored according to the 
MRC grading scale.
Molecular genetics. DNA was extracted from whole 
blood in EDTA using standard methods. Exons 1-24 of 
SCN4A,  the  gene  encoding  the  major  sodium  channel 
protein  Nav1.4  of  skeletal  muscle,  were  amplified  by 
polymerase chain reaction (PCR), and the products ex-
amined for mutations by direct PCR sequencing using an 
automated 373A sequencer (Applied Biosystems). Sam-
ples were bidirectionally sequenced. The primers and the 
cycling conditions were reported in Heine et al. (5). Par-
ticularly, the primers used for exon 9 in which an altera-
tion was identified were atccgtttggtttatgtggt (forward) and 
ccctggggtgccttttctgc (reverse). This exon was sequenced 
in 200 control individuals for comparison. To find out 
whether the genetic alteration is disease-causing or just a 
benign polymorphism, LOD scores were calculated with 
MLINK of the linkage package using an assumed pen-
etrance of 99% and an allele frequency of 1:100,000. In 
addition, exons 1-23 of CLCN1, the gene encoding the 
major  chloride  channel  ClC1  of  skeletal  muscle  were 
sequenced in the same way by use of primers reported 
by Lehmann-Horn et al. (14). To test for an exon-wide 
deletion or duplication on one allele that would not be 
identified  by  the  method  above,  multiplex  ligation-de-
pendent probe amplification (MLPA) analysis was per-
formed. We used a commercially available kit (SALSA 
MLPA kit P350-A1 CLCN1) according to the manufac-
turer’s guidelines (MRC-Holland, Amsterdam). This kit 
contained probes for all 23 CLCN1 exons. A patient vs. 
control product ratio of > 1.25 suggests a duplication and 
a ratio of < 0.75 a deletion.
Results
The proband is a 47 year old Turkish man (Fig. 1, 
arrow),  presenting  with  myotonia,  generalized  muscle 
hypertrophy,  and  weakness  episodes.  Muscle  stiffness 
had already been observed in infancy. Once in childhood, 
swimming in warm water caused a life-threatening weak-
ness  of  the  exercised  muscles.  Cold  sensitivity  of  the 
musculature was denied. On average once a month, an 
episode of weakness provoked by exercise occurs in dis-
tal muscles and can last for 2 to 3 days. In his family there 
are 9 additional affected members (Fig. 1).
The  neurological  examination  of  the  proband  re-
vealed  percussion  myotonia  and  myotonic  stiffness  of 
distal muscles and – after strenuous contraction – stiff-
ness of proximal and neck muscles. Muscle relaxation 
lasted  several  seconds  up  to  30  seconds.  Both  eyelid 
and limb muscles revealed a warm-up phenomenon. The 
EMG exhibited marked myotonic activity in all muscles 
Table 1. Clinical features of the various forms of myotonia.
Features Chloride channel myotonia Sodium channel myotonia
Becker and Thomsen PAM PMC HyperPP
Trigger for myotonia Rest Potassium, exercise Cold, exercise Potassium, exercise 
Trigger for flaccid 
weakness
Fasting, exercise -- Cold Potassium, exercise, 
cold
Warm-up 
phenomenon
++ + + in warmth, 
-  in the cold
+
Paradoxical myotonia -- Only in eyelid 
muscles
Always 
in the cold
-
Therapy Antiarrhythmics, 
acetazolamide?
Antiarrhythmics, 
acetazolamide
Antiarrhythmics Hydrochlorothiazide, 
acetazolamideNa+ channel myotonia with weakness
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tested. Nerve conduction velocities of the median nerve 
and distal latencies were normal. Bicycle exercise (75 W) 
caused an increase in myotonic stiffness of most muscles 
and weakness of the flexors of the hands (MRC 4) with-
out a pathological serum potassium deviation in the post-
exercise phase. The cooling test did not result in weakness 
while exercise of the cooled muscles revealed the same 
myotonic stiffness as observed in ambient temperature.
Examination  of  affected  family  members  allowed 
to collect additional information: One nephew reported 
provocation of flaccid weakness and muscle cramps due 
to potassium-rich food in addition to exercise-induced 
weakness. He exhibited grip myotonia and a dispropor-
tionate figure with poorly developed and weak muscles 
of the neck and the upper limb girdle whereas the lower 
limble girdle muscles were hypertrophied. The muscle re-
flexes were absent in the upper extremities and normal in 
the lower extremities. The clinical presentation was thus 
reminiscent  of  Becker  myotonia.  The  EMG  displayed 
many myotonic runs and normal motor nerve conduc-
tion velocities. Potassium provocation resulted in muscle 
weakness (MRC 4). Two other nephews reported spells 
of weakness following fasting and exercise, difficulties 
to relax the fist but no substantial sensitivity to cold. In 
the affected family members, CK was often elevated to 
values up to twice the upper normal limit. Several fam-
ily members responded well to hydrochlorothiazide and 
acetazolamide. However, they chose not to take the drugs 
regularly but preferred using them as needed in particular 
when they noticed the beginning of an episode of weak-
ness. They reported that with the drugs the severity of 
weakness could be mitigated.
Genetics: Exon 9 of all affected family members re-
vealed a c.1320T>G base exchange predicting a p.N440K 
substitution (Fig. 2). The replaced amino acid N440 is 
situated in segment 6 of repeat I (Fig. 3). N440 is con-
served among all human voltage-gated sodium channels. 
No other SCN4A mutation was found in the proband. No 
CLCN1 alteration was identified in the coding sequence 
and the exon-intron boundaries. MLPA identified neither 
an exon-wide deletion nor an exon duplication (Fig. 4).
Discussion
The exact clinical diagnosis in this family was dif-
ficult to make as the features did not fit into the current 
classification of myotonias (Tab. I). The phenotype re-
sembled a combination of PAM because of the myotonia, 
and HyperPP because of the potassium- and exercise-in-
duced weakness in two family members. However PAM 
is not associated with weakness, and HyperPP shows no 
exercise-induced muscle stiffness.
Careful clinical analysis is important because the vari-
ous symptoms need to be treated appropriately. Myotonia 
can be best treated by the lidocaine-like, orally administered 
tocainide and mexiletine. Unfortunately, these agents have 
been taken of the market. Nevertheless myotonic symptoms 
and the cold-induced weakness of paramyotonia respond 
to the modern antiarrhythmic drugs flecainide and propaf-
Figure 1. Pedigree of the Turkish family. The affected 
members  harbor  the  N440K  sodium  channel  mutation 
while the non-affected do not.
Figure 2. A comparison of the SCN4A sequence of a forward 
(F) fragment of exon 9 of the proband with the c.1320T > G 
base exchange (p.N440K) and from a control (WT). This al-
teration was absent in all 200 control individuals.F. Lehmann-Horn et al.
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enone (16). However, these agents do not prevent sponta-
neous and hyperkalemia-induced weakness episodes. These 
features respond to potassium-sparing diuretics such as hy-
drochlorothiazides and acetazolamide. In addition, frequent 
meals rich in carbohydrates and a low-potassium diet may 
also prevent weakness episodes like in HyperPP.
In the Turkish family reported here, we have performed 
CLCN1 studies since the myotonia was predominant in all 
family members and the recessive Becker myotonia is unu-
sually frequent in this population, probably because of the 
high incidence of consanguineous marriages. We excluded 
CLCN1 mutations by conventional PCR and direct sequenc-
ing as well as, to our knowledge for the first time, CLCN1 
exon deletions and duplications by MLPA analysis.
We have identified a novel SCN4A alteration that ful-
fills the criteria of a disease-causing mutation: i) the base 
exchange perfectly segregates with the phenotype; ii) it 
does not occurr in a high number of healthy controls; iii) 
it predicts an amino acid exchange in a highly conserved 
area of functional importance, and finally the calculated 
LOD score of 2.99 is high enough. The N440K amino acid 
substitution N440K is situated deeply in the S6 segment of 
repeat I, and it is in the vicinity of V445M, a PAM muta-
tion (17). V445M is located in the adjacent N-terminal area 
of the loop connecting repeats I and II (Fig. 3). Although 
we have not yet performed functional expression of the 
N440K mutation, its location at the inner end of the S6 seg-
ment allows us to anticipate that the mutant channel will 
resemble both the HyperPP mutation M1592V (18) and the 
PAM mutation V1589M (5), both residing at the inner end 
of the S6 segment of repeat IV. Both mutations caused a 
slight permanent inward current through the central chan-
nel pore, slightly shifted the steady-state activation curve, 
and destabilized the fast inactivation state without slowing 
fast inactivation (8, 19) and without impairing slow inacti-
vation (20). This pattern is different from PMC mutations 
which usually markedly slow fast inactivation.
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Figure 4. Multiplex ligation-dependent probe amplification (MLPA) analysis of all 23 CLCN1 exons. The upper panel 
shows the peaks whose area and amplitude correspond to the efficiency of the amplification which usually is smaller at 
the right end; particularly the fifth peak from the right is always small. The numbering corresponds to the length (in base-
pairs) of the products. The middle panel shows the histograms (blue: average of control products, green: products of the 
patient´s sample) for the 23 exons. The lower panel displays the ratio patient vs. controls. As all ratios were between 0.75 
and 1.25, an exon duplication or deletion is excluded. The analysis also contains an exon-1 probe and 3 exon-2 probes 
for KCNJ2, another gene analyzed by this commercial kit (on the right of the middle and the lower panels).